Literature DB >> 1618887

Interferon and interleukin-2 induced spontaneous cell-mediated cytotoxicity: a preliminary evaluation.

P Balaram1, M R Pillai, T Abraham, K R Nalinakumari, G Meenattoor, S Kannan, N K Hareendran, M K Nair.   

Abstract

The contribution of natural cell-mediated cytotoxicity and its modulation with biological response modifiers in antitumour immunity was evaluated in patients with precancers and cancers of the oral cavity. The results were compared to those in normal controls. Both groups of patients showed highly significant depression of the natural killer cell activity. This depression was stage-related, suggesting an influence of tumour or tumour products on this activity. Depression in augmentation of this cytotoxicity was evident in both patient groups with cancers and precancers, suggesting a defect in the response of killer cells to biological response modifiers for reasons other than the tumour per se.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618887     DOI: 10.1007/bf01629422

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: clinical implications for oral precancerous lesions.

Authors:  M R Pillai; P Balaram; S Kannan; L Sudha; K R Nalinakumari; N K Hareendran; M K Nair
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1990-10

Review 2.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 3.  The role of natural killer cells in the control of tumor growth and metastasis.

Authors:  N Hanna
Journal:  Biochim Biophys Acta       Date:  1985

4.  Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate.

Authors:  E A Grimm; J A Thoma; B Bonavida
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

5.  Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexes.

Authors:  P Balaram; M R Pillai; T Abraham
Journal:  J Oral Pathol       Date:  1987-09

6.  Quantitation of Fc receptor-bearing T-lymphocytes (TG and TM) in oral cancer.

Authors:  P Balaram; D M Vasudevan
Journal:  Cancer       Date:  1983-11-15       Impact factor: 6.860

7.  Natural killer cell activity and head and neck cancer: a clinical assessment.

Authors:  S P Schantz; E J Shillitoe; B Brown; B Campbell
Journal:  J Natl Cancer Inst       Date:  1986-10       Impact factor: 13.506

8.  Immune function in malignant cervical neoplasia: a multiparameter analysis.

Authors:  P Balaram; M R Pillai; T K Padmanabhan; T Abraham; N K Hareendran; M K Nair
Journal:  Gynecol Oncol       Date:  1988-11       Impact factor: 5.482

9.  Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.

Authors:  A Uchida; M Micksche
Journal:  Int J Cancer       Date:  1983-07-15       Impact factor: 7.396

10.  Lymphocyte populations in premalignant lesions and cancer of the oral cavity.

Authors:  M R Pillai; P Balaram; T Abraham; M K Nair
Journal:  Neoplasma       Date:  1987       Impact factor: 2.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.